BS EN 13624:2021
Chemical disinfectants and antiseptics. Quantitative suspension test for the evaluation of fungicidal or yeasticidal activity in the medical area. Test method and requirements (phase 2, step 1)
Standard number: | BS EN 13624:2021 |
Pages: | 56 |
Released: | 2022-03-11 |
ISBN: | 978 0 539 04818 6 |
Status: | Standard |
BS EN 13624:2021 - Chemical Disinfectants and Antiseptics
Standard Number: BS EN 13624:2021
Pages: 56
Released: 2022-03-11
ISBN: 978 0 539 04818 6
Status: Standard
Overview
The BS EN 13624:2021 standard is an essential document for professionals in the medical and healthcare sectors. This comprehensive standard provides a detailed quantitative suspension test method for evaluating the fungicidal or yeasticidal activity of chemical disinfectants and antiseptics. It is specifically designed for use in the medical area, ensuring that the products meet stringent requirements for efficacy and safety.
Key Features
- Comprehensive Testing Method: The standard outlines a rigorous and detailed test method to evaluate the effectiveness of chemical disinfectants and antiseptics against fungi and yeasts.
- Medical Area Focus: Tailored specifically for the medical field, ensuring that the disinfectants and antiseptics used in healthcare settings are effective and safe.
- Phase 2, Step 1: This standard represents the first step in the second phase of testing, providing a foundational evaluation of fungicidal and yeasticidal activity.
- Up-to-Date Information: Released on March 11, 2022, this standard includes the latest research and methodologies in the field of chemical disinfection and antiseptics.
Detailed Description
The BS EN 13624:2021 standard is a critical resource for ensuring the efficacy of chemical disinfectants and antiseptics in medical environments. This document provides a quantitative suspension test method, which is a crucial tool for evaluating the fungicidal or yeasticidal activity of these products. The test method is designed to simulate real-world conditions in medical settings, providing reliable and accurate results.
The standard is divided into several sections, each detailing a specific aspect of the test method. These sections include the preparation of test organisms, the preparation of test solutions, the execution of the test, and the interpretation of results. Each section is meticulously detailed, providing clear and concise instructions to ensure consistency and accuracy in testing.
One of the key features of the BS EN 13624:2021 standard is its focus on the medical area. The test method is specifically designed to evaluate the effectiveness of disinfectants and antiseptics used in healthcare settings, where the control of fungal and yeast infections is critical. This focus ensures that the products tested using this standard are suitable for use in hospitals, clinics, and other medical facilities.
The standard also includes detailed requirements for the test method, ensuring that the results are reliable and reproducible. These requirements cover aspects such as the concentration of test organisms, the contact time, and the temperature at which the test is conducted. By adhering to these requirements, professionals can ensure that their testing is consistent with the highest standards of quality and accuracy.
Benefits
- Ensures Efficacy: By following the test method outlined in the standard, professionals can ensure that the disinfectants and antiseptics they use are effective against fungi and yeasts.
- Enhances Safety: The standard helps to ensure that the products used in medical settings are safe for both patients and healthcare workers.
- Supports Compliance: Adhering to the standard helps organizations comply with regulatory requirements and industry best practices.
- Improves Quality Control: The detailed test method and requirements help to improve the quality control processes for disinfectants and antiseptics.
Who Should Use This Standard?
The BS EN 13624:2021 standard is an invaluable resource for a wide range of professionals in the medical and healthcare sectors, including:
- Healthcare Providers: Hospitals, clinics, and other healthcare facilities can use this standard to ensure the effectiveness and safety of the disinfectants and antiseptics they use.
- Laboratories: Testing laboratories can use the standard to conduct reliable and accurate evaluations of fungicidal and yeasticidal activity.
- Manufacturers: Manufacturers of chemical disinfectants and antiseptics can use the standard to develop and test their products, ensuring they meet the highest standards of efficacy and safety.
- Regulatory Bodies: Regulatory agencies can use the standard to establish guidelines and requirements for the use of disinfectants and antiseptics in medical settings.
Conclusion
The BS EN 13624:2021 standard is a comprehensive and essential resource for evaluating the fungicidal and yeasticidal activity of chemical disinfectants and antiseptics in the medical area. With its detailed test method and stringent requirements, this standard ensures that the products used in healthcare settings are both effective and safe. Whether you are a healthcare provider, laboratory technician, manufacturer, or regulatory body, this standard provides the guidance and tools you need to ensure the highest standards of quality and safety in your work.
BS EN 13624:2021
This standard BS EN 13624:2021 Chemical disinfectants and antiseptics. Quantitative suspension test for the evaluation of fungicidal or yeasticidal activity in the medical area. Test method and requirements (phase 2, step 1) is classified in these ICS categories:
- 11.080.20 Disinfectants and antiseptics
Biological evaluation of medical devices Evaluation and testing within a risk management process
Biological evaluation of medical devices Tests for in vitro cytotoxicity
Biological evaluation of medical devices Tests for skin sensitization